- Home
- ESP vs TCRX Comparison
ESP vs TCRX Comparison
Compare ESP & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- TCRX
- Stock Information
- Founded
- ESP 1928
- TCRX 2018
- Country
- ESP United States
- TCRX United States
- Employees
- ESP N/A
- TCRX N/A
- Industry
- ESP Industrial Machinery/Components
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- TCRX Health Care
- Exchange
- ESP Nasdaq
- TCRX Nasdaq
- Market Cap
- ESP 148.8M
- TCRX 140.7M
- IPO Year
- ESP N/A
- TCRX 2021
- Fundamental
- Price
- ESP $37.63
- TCRX $1.14
- Analyst Decision
- ESP
- TCRX Strong Buy
- Analyst Count
- ESP 0
- TCRX 6
- Target Price
- ESP N/A
- TCRX $8.80
- AVG Volume (30 Days)
- ESP 18.2K
- TCRX 890.4K
- Earning Date
- ESP 11-12-2025
- TCRX 11-07-2025
- Dividend Yield
- ESP 2.60%
- TCRX N/A
- EPS Growth
- ESP 31.88
- TCRX N/A
- EPS
- ESP 3.02
- TCRX N/A
- Revenue
- ESP $43,950,872.00
- TCRX $6,961,000.00
- Revenue This Year
- ESP N/A
- TCRX $255.18
- Revenue Next Year
- ESP N/A
- TCRX N/A
- P/E Ratio
- ESP $12.36
- TCRX N/A
- Revenue Growth
- ESP 13.46
- TCRX N/A
- 52 Week Low
- ESP $24.85
- TCRX $1.02
- 52 Week High
- ESP $55.00
- TCRX $6.23
- Technical
- Relative Strength Index (RSI)
- ESP 47.47
- TCRX 26.50
- Support Level
- ESP $37.19
- TCRX $1.08
- Resistance Level
- ESP $39.82
- TCRX $2.43
- Average True Range (ATR)
- ESP 1.48
- TCRX 0.17
- MACD
- ESP 0.29
- TCRX -0.15
- Stochastic Oscillator
- ESP 56.18
- TCRX 4.42
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.